TSHA Taysha Gene Therapies, Inc.
4.430USD+0.91%Mkt Cap: 1.44B $P/E: —1d ago
Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central ner…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap1.44B USD
Enterprise Value1.03B USD
Revenue (TTM)5.49M USD
Gross Profit5.49M USD
Net Income (TTM)-109.00M USD
Revenue/Share0.01 USD
Last Price4.430 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.49
PEG—
EV/EBITDA-6.79
EV/Revenue188.10
P/S260.79
P/B3.69
EPS (TTM)-0.41
EPS (Forward)-0.46
52W Range
2.91035% of range7.300
52W High7.300 USD
52W Low2.910 USD
Profitability
Gross Margin100.00%
Oper. Margin-2792.32%
EBITDA Margin0.00%
Profit Margin-1115.27%
ROE-44.14%
ROA-31.75%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-93.09M USD
CapEx (TTM)738.00K USD
FCF Margin-1476.13%
FCF Yield-5.61%
Net Debt-398.69M USD
Net Debt/EBITDA2.62
Balance Sheet
Debt/Equity0.28
Current Ratio17.77
Quick Ratio17.53
Book Value/Sh1.19 USD
Cash/Share1.40 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.00 USD
Upside (mean)+193.5%
Target Range9.000 USD – 19.00 USD
9.000+193.5% to mean19.00
# Analysts13
Ownership
Shares Out.325.83M
Float232.62M
Insiders9.45%
Institutions94.06%
Short Interest
Short Ratio19.7d
Short % Float16.03%
Short % Out.15.78%
Shares Short51.41M
Short (prev mo.)46.74M
Technical
SMA 505.597 (-20.8%)
SMA 2005.449 (-18.7%)
Beta1.17
S&P 52W Chg16.45%
Avg Vol (30d)3.11M
Avg Vol (10d)4.74M
Technical Indicators
RSI (14)30.6
MACD-0.3270
MACD Signal-0.2976
MACD Hist.-0.0294
BB Upper5.590 USD
BB Middle4.938 USD
BB Lower4.285 USD
BB Width26.44%
ATR (14)0.2717 USD
Vol Ratio (20d)1.06x